A brief glance at any pharmacological book or treatise on therapeutics will reveal that there are actually only a handful of -drugs which have been advocated for the relief of pain. All of these have been in clinical use for many years, and their usefulness in thie treatment of pain in general, or for the treatment of a specific condition, has been accepted as colmmon knowledge and medical teaching. Unfortunately, the dinician too often prescribes an analgesic and, without any further follow-up, assumes tha;t the patient had relief of pain. Because this was the medication advocated for this condition, the expected response must have occurred. If the patient does not respond in the accepted manner, he is considered to be a psychoneurotic with magnification of his symptoms. Of course, the drug is never at fault. Occasionally the converse occurs, particularly when new analgesic agents are used and an over-zealous investigator may have primed the patient about the anticipated benefit. Although the patient may not have noted any particular alleviation of the pain, he feels that since the doctor is making all efforts to help him, it would be discouraging to give a negative report. The patient, always respectful of the physician and somewhat overwhelmed by the unusual attention, invariably claims to be improved.
The problem is at once apparent. A study of analgesic agents is meaningless unless one considers the symptom of pain as it is manifested by the individual patient. We cannot, at the present, divorce the complaint from the patient as a whole. Pain is a subjective symptom. Recent work has emphasized the pain threshold and reactivity of the patient,2' 4, particularly alterations in facial expressions resulting from application of a known stimulus such as intense heat or inflated balloons. These methods are very import-ant contributions to the subject of pain and its treatment, but do not satisfy or replace the clinical need for careful analysis of the individual's pain symptom complex and response to therapy. There is no question that the reactivity to a painful stimulus varies markedly from subject to subject and even in the same individual from time to time. Under standardized conditions this is a measurable quantity in the hands of capable investigators and intelligent subjects. Consider the difficulties, however, of evaluating the complaints of a patient who is supposedly in distress on the basis of organic disease. In addition to the perception of the painful stimulus, every patient varies to an astounding degree in the development of associated ideas or introspective ainalyses of the responsible factor for the discomfort. One patient may noit be distressed by the severest form of pain, while another, because of fear of sudden death, or of the possibility of a fatal disease, reacts almost explosively both physiologically and psychologically to the mildest type of pain. The fact that must be emphasized is that we possess no means of accurately evaluating the severity, quality, and duration of the pain except by careful history. The patient's description of th'e symp-tom is our sole guide to its severity, and should be accepted as such regardless of the underlying disease or psychological make-up of the patient. The clinician, on th'e basis of experience and appreciation of the latter factor, may more accurately gauge the significance of the complaint, but he cannot and should not in any way deny the presence of the pain or its stated severity. This dilemma also holds true for evaluating the response to therapy. The patient may appear more comfortable and anxiety is lessened, 'but other than these questionable objective signs, one must rely on the patient's admission of the degree of relief. The production of sleep following the administration of the analgesic is not a sign of relief of pain, but rather an additional action of the drug upon the central nervous system. By definition, analgesics are a group of drugs which relieve pain without loss of consciousness. Although, in some patients, it may be advantageous to have sleep produced, it is not a function of analgesia and in most instances is undesirable.
Th'e W.Tolff, Hardy, and Goodell technique2 4' for evaluating the effectiveness of analgesic agents by deterrmining the pain threshold contributed greatly to our knowledge of these drugs. However, it is well recognized and has been emphasized by Wolff and asso- ciates themselves that the elevation of the pain threshold is only one of the possible modes of action of analgesics. It is probable, in light of clinical experience, that it is of minor importance in regard to analgesic effectiveness when such drugs are administered for the relief of pain. Overwhelming evidence has accumulated to substantiate this interpretation. Excluding for the moment those drugs which, in spite of a negligible or even absent effect upon the pain threshold, exert a marked analgesic action when given for specific conditions; for example, colchicine for gout and salicylates for rheumatic fever; the majority of analgesic agents exert their main action within the central nervous system. Considering the various levels of integration of pain which exist within the central nervous system, the cerebral cortex, thalamus, tectum mesencephali, and perhaps the internuncial pool of neurons within the central gray matter of the .pinai curci, t iee aalgesic may hypothetically alter the transmission of the pain impulse from the periphery to the cerebral cortex where the consciousness or awareness of the pain is manifest. The cerebral cortical level appears to be the most important. Not only is this the highest level for normal appreciation of pain, but this perception may be altered by other cortical centers. Thus, an individual under excitement or emotional stress may not be aware of a painful wound. Mental processes also affect the perception of pain. Wolff and Goodell7 have demonstrated that with suggestibility, variability in moods, anticipation of an expected response, and other psychic factors, the pain threshold may be raised to a level equivalent to that achieved with mild analgesic drugs. Emphasis for the action of analgesics is placed upon the ability of the drug to alter the reactivity of the patient to the disturbing symptolms. Those drugs which possess a marked psychic effect on the individual are the most potent as regards analgesia. Thus, it is commonly accepted that the patient is still aware of pain but he is no longer perturbed by its presence. In other words, the fear and associated implications are decreased or abolished. 'This theory explains, perhaps, why morphine and demerol continue to exert an analgesic action long after a tolerance to the peripheral pain threshold effect occurs. It also attempts to explain the analgesic effects of a placebo. With suggestibility, the pain threshold may be elevated after administration of a placebo, but this response is never great nor prolonged. In our experience, regardless of the severity of pain or the underlying organic disease, a placebo will result in analgesia in approximately 40 per cent of the trials. In solme instances this response is indistinguishable from that achieved with the accepted potent analgesics and may be produced repeatedly. A patient may even be psychically addicted to the placebo and demand its continued administration. It is apparent that in evaluating analgesic drugs, they must exceed in effectiveness the expected incidence of response to a placebo, before they can be accepted as analgesic agents. Furthermore, the common practice of adminfistering a placebo after a course of a potent analgesic and because of a response classifying the patient as a psychoneurotic is entirely unjustified. Not onlv will the patient respond to the placebo because of the anticipation of relief, but an entirely new mechanism becomes evident. In attempting to study the addiction liability of demerol, a group of patients who had been treated for pain over a period of months were given, without itheir knowledge, a placebo according to the same dosage schedule. Much to our amazement, the patients continued to have analgesia for periods of 24 to 96 hours, at which time the placebo gradually became less and less effective and pain recurred to the level existing before analgesia was achieved at the onset with demerol. Incidentally, none of these patients presented signs and symptoms of abstinence phenomena indicative of physical dependence. These patients were either conditioned to the analgesic response so that, for variable periods thereafter this response could be elicited by other drugs, or else a potent analgesic, after prolonged use, may alter the physiological responses within the central nervous system so that a persistence of effect may exist even though the drug is no longer present within the body. That the latter is probably the most likely explanation appears from a duplication of the above experiment, but this time without the use of placeboes. Discontinuing entirely the administration of the analgesic, the same results are achieved, ithe patient continuing to be free of pain for 24 to 96 hours. That persistence of action is not an unusual pharmacollogical response can be readily appreciated when one considers other clinical examples such as continued relief of intercostal pain resulting from a rib fracture by a single nerve injection of procaine. Alithough one cannot escape the impression that the psychological component is perhaps th;e most important action of an analgesic, it seems that the integrating levels below the cortex should not be entirely neglected. I 'have in mind experiences in morphine addicts which perhaps indicate a midway action. It is well recognized that morphine addicts will develop a marked tolerance to the drug so that large doses are necessary to achieve a repe-tition of an euphoric response. It is also well known that every effect of morphine which will produce the phenomenon of tolerance does so with independent dosage levels. Thus, each indivi'dual has an optimum dose level which will give a desired action. The tolerance to the analgesic action of morphine tapers off when 30 to 45 mg. are reached, but there-is no apparent limit for the euphoric or psychic response. Why is it then, that morphine addicts, if pain is present, will respond to a dose of morphine which is relatively very small and will not piroduce a psychic effect? Since most analgesics have pharmacological actions upon suibcortical areas, it is conceivable that they may exert a "blocking" effect at one of the lower integrating levels. It has been stated7 that even after pain is relieved subjectively certain patients continue to be aware of their pain. In my experience, this is not necessarily true. The majority of patients have compliete cessation of the pain with recurrence of the perception when the drug is dissipated. It is, therefore, my conclusion that the central action of analgesics is a combination of the psychic together with some interference with the sensation reaching the consciousness. In any individual patient, either feature may play the dominant role, ;but both are probably coexisting.
'The next problem confronting the physician is what types of pain occur clinically. Regardless of its severity and duration, pain can be classified according to four major groups. The largest number of patients present pain secondary to some inflammatory or pathological process involving visceral or musculo-skeletal structures. This includes every organ of the body and represents the type of pain seen postoperatively, with malignancies, surgical wounds, fractures, arthritis, gangrene, and pleural, pericardial, peritoneal, and meningeal irritations as typical examples. The second largest group of patients possess pain of neurological origin and include non-specific headaches, neuri'tis, neuralgias, and root pains. The third group of patients present themselves with spasms of smooth muscle involving the gastro-intestinal, genito-urinary, biliary, or circulatory systems. Finally, there exists a group of patients who, as far as can be determined, do not possess any organic or functional explanation for their complaints, with the result that the pain is classified as psychalgia. This, of course, is the hardest diagnosis to make and should be made as the last resort and only after prolonged, careful study.
The choioe of an analgesic agent must depend on several other factors. The severity of the pain requires careful consideration.
Regardless of the etiological factor, it is convenient to suibdivide the severity into very severe, moderately severe, and mildly severe. As pointed out previously, this is dependent entirely upon the patient's own admission, but it must be templered by the appearance of the patient, including the general physical and associated symptoms. The duration and the constancy of the pain decidedly influence the choice and evaluation of an analgesic. If the pain is constant, such as is seen with malignancies or surgical conditions, a short acting or rapidly dissipating drug may not show up to advantage in spite of the fact that complete analgesia is obtained for one to hours. Upon recurrence of the pain, the patient invariably will report that the analgesic was not effective. It is too much to expect the patient to appreciate the fact that the medication does not eradicate the disease but only alleviates a symptom.
The physician should also be aware that potent analgesic drugs, probably on the basis of unpredictable untoward reactions, do not lend themselves readily to the treatment of ambulatory patients. It is true that the majority of such patients do not possess severe pain, but we are definitely restricted in -the use of analgesics becausie the mild preparations available at the present time are not very effective and the potent preparations may produce unpleasant side reactions which not only require caution in their use, but also depreciate their usefulness. The best example of this is the use of demerol in ambulatory patients.' Side reactions are very common and may occur in 70 per cent of the patients, while the incidence for the same dose and route of administration for hospitalized and recumbent patients is no higher than 27 per cent. All analgesic agents have a higher incidence of untoward reactions for ambulatory patients, but because they are not too serious they are often overlooked and are not regarded as significant. This brings up the necessity of studying all new analgesic agents in ambulatory as well as in hospitalized patients. Sometimes unusual reactilons not encountered in bedridden patients become evident. Recently, we had the opportunity to study a new analgesic drug, a trimethyloxazolidine derivative which had the clinical potency of codeine. Hospitalized patients could tolerate tremendous doses, both intravenously and orally with little if any toxicity. When the drug was given to ambulatory patients, however, practically all returned with the similar story of marked visual disturbances. In several instances, the patient had consulted an optometrist because the refractory index was changed. Every patient, however, fortunately had restoration of normal vision upon discontinuance of the drug.
The preceding discussion has indicated in general the various factors that are considered in clinically evaluating new analgesic drugs. To be more explicit, the drug is considered for clinical use when the pha'rmacological data in laboratory animals indicate its toxicity, its cardiovascular and respiratory actions, as well as its ability to raise the pain threshold. The drug is then administered to both hospitalized and ambulatory patients with every type and severity of pain. For the hospitalized patient, the parentetral route of administration is preferable since, if the drug has an analgesic action, its effect will be noted promptly, and usually within 15 minutes. At first, very little attention is paid to the possibility of analgesia, since nothing is known about the effective dose. Emphasis is upon untoward reactions, and on cardiovascular and respiratory actions. When the minimal effective safe dose is determined the drug is used freely in place of the accepted analgesics. The effectiveness of the analgesic is then analyzed according to four categories.
(1) Complete control of pain, including complete relief of pain for three or more hours and al;most complete relief of pain for several hours. In this group untoward reactions are minimal or entirely absent. (2) Moderate control of pain, including complete relief and almost complete relief of pain for under three hours, partial relief for three hours or more and relief as described in the first category if untoward reactions are disturbing and do not permit complete comfort. (3) Slight control of pain, including partial relief for under three hours and relief as described in the first and second categories if untoward reactions are moderately severe. (4) No control of pain, including failure to affect pain and relief as described in the first 3 categories if untoward reactions are severe. In our experience, an effective analgesic, regardless of its ultimate potency, should give, by the parenteral route, satisfactory control of pain in over 60 per cent of the trials and if given orally in between 40 and 60 per cent. If the drug possesses specificity for a particular disease or function, then the incidence should approach 80 to 90 per cent.
We can thus set forth the following criteria for effective and suitable analgesic agents.
(1) The drug should be reliable in producing satisfactory analgesia, regardless of the underlying pathological disease. Analgesics for severe pain should be capable of producing satisfactory control when administered parenterally in 90 to 95 per cent of the trials, and in 60 to 70 per cent when administered orally.
(2) Since a large number of patients have severe pain on the basis of spasm of smooth muscle, it would be an advantage to have a drug with analgesic and antispasmodic actions. At least the drug should not result in further spasm of smooth muscle throughout the body; an action which in some instances may be detrimental to the patient's welfare.
(3) The drug should have little or no untoward reactions, particularly upon the carditovascular and resipiratory systems.
(4) When administered orally to ambulatory patients, the drug should be capable of allevialting moderate degrees of pain for several hours without an increased incidence of side reactions.
(5) A somnifacient or sedative action should be minimal or nonexistent.
(6) Prolonged use of thie drug should not result in cumulation. (7) Repeated administration should be free of tolerance, so that the same analgesic effect will always be expected with the same dose.
(8) The drug should not lead to addiction. We are more concerned with the development of physical dependence than psychic addiction, since it is unlikely that any potent drug possessing a beneficial action of analgesia would be free of the latter stigmata.
(9) The drug must be safe to be administered to patients of all ages and in all diseases without fear of contraindication or potentiation of an untoward response.
(10) Finally, there are some minor considerations, such as ease of administering the drug, irritation upon injection or ingestion, deterioration on storage, and so forth.
In the light of these criteria let us consider a new synthetic analgesic introduced in 1943 by Dodds, Lawson, and Williams.3 These investigators pointed out the chemical relationship of diphenylethylamine to morphine and presented pharmacological and preliminary clinical data indicative of the analgesic action of this group of compounds. The most promising was the beta-hydroxy alpha beta diphenylethylolamine. Our studies consisted in administering both the "normal" as well as the "iso" form of this compound to a group of 104 patients presenting a wide variety of painful conditions. The study was carried out with three groups of patients for each preparation. Hospitalized patients were treated both orally and paren-terally, while ambulatory patients were given only the oral preparation. With doses from 50 to 200 mg. (average 100 mg.) every 4 hours we were able to demonstrate an analgesic action of only 54 per cent effectiveness for either preparation and by all routes. The drug was, therefore, not very reliable in producing analgesia. This is particularly so for the parenteral route which would ordinarily be used for severe pain. Side reactions for the hospitalized patients were of minor significance and took the form of an occasional occurrence of nausea, vomiting, and dizziness. Ambulatory patients, however, presented in addition to these, faintness, headache, aniorexia, perspiration, and constipation. Since these occurred with a dose which gave only slight analgesia or none at all, it was very difficult in this group of patients to obtain the proper therapeutic dose. For the hiospitalized patients, however, the oral preparation appeared to be satisfactory for the mild to moderate types of pain. The questions of tolerance, accumulation, and addiction remain unanswered, since the analgesic potency of this compound precluded further investigation with it.
No discussion of analgesia would be complete without a brief consideration of morphine. This drug has been generally accepted as the standard for analgesics, since, without question; it is the most patent of all. By any means of study, whether by pain threshold measurements or by actual clinical trial, it is supreme for analgesia. Regardless of the severity of the pain or the responsible underlying pathological process, an appropriate dose given subcutaneously will result in relief of pain in over 90 per cent of the patients so treated. Duration of analgesia is primarily dependent upon the severity of the pain, but is usually 3 hours. In the vast majority of patients this is as long as one would wanit an analgesic to be active. A more prolonged action would materially interfere with and depreciate a valuable clinical sign of the patient's progress, namely, the persistence of the pain. However, in many patients, such as those with advanced malignancies, where this is not a factor, a drug producing relief of pain for no longer than 3 hours may be considered to be unsatisfactory. This is particularly so if repetition of the drug at 3-hour or even 4-hour intervals may result in cumulation of untoward reactions such as profound narcosis or respiratory depression. These reactions will be considered in a moment, but we cannot escape the fact that this drug admirably meets the first of our criteria for an effective and suitable analgesic agent. However, upon further analysis it is at once apparent that the drug possesses many serious disadvantages which definitely impair its usefulness. First of all, a therapeutic dose always results in a spasmogenic action upon the smooth muscle of the gastro-intestinal, biliary, genito-urinary, and respiratory tracts. Thus, a patient with colicky pain arising from any smooth muscle origin not only has an increase in muscle spasm but this in turn may also increase the pain temporarily until the central analgesic action becomes evident. To counteract this action, atropine (or its derivatives) is usually administered simultaneously. Why should it be necessary to use another drug to offset an unquestionably undesirable action of an analgesic?
Upon the gastro-intestinal tract the drug in addition invariably produces a generalized increase in tone and spasm of the sphincters which delays the normal emptying time of the stomach and possibly interferes with normal digestive functions and also results in constipation. This is a desirable action for the treatment of diarrhea, but why should a patient receiving relief of pain be made uncomfortable with constipation, especially since the constipation is not easily rectifiied by the usual medication when the analgesic is administered over a prolonged period? Granted that in most patients this is of minor consequence, in postoperative patients it may definitely interfere with the proper management of bowel function and probably contribute to postoperative distension and ileus.
Spasm of the trigone muscle of the urinary bladder with urinary retention is not uncommon. This action in postoperative patients may result in serious consequences necessitating frequent catheterizations and possible development of ascending genito-urinary infections. Elderly males with hypertrophied prostates, in particular, must be observed very carefully if one wishes to avoid uremia.
Spasm of the bronchial musculature in the majority of patients is of no consequence, but may be dangerous if the patient has bronchial asthma. Numerous examples of the seriousness of this action and the possibility of 'the patient's sudden death can be found in the literature.6
Untoward reactions other than smooth muscle spasm are very common. The most important is depression of respiration. All patients to some degree present this action, but it is serious in only a few. Since it occurs readily in patients with cerebral arteriosclerosis, marked de-bilitation, anemias, and intercranial diseases, such as brain tumors, and in skull fractures, morphine must be used with caution or not at all in these cases. Although it may not occur with the initial dose, it may if doses are repeated every 4 hours or oftener. This definitely impairs its usefulness in patients with chronic pain, because as the effects of analgesia subside in 3 hours the respiratory effects are more prolonged and readily cumulate with repeated doses. This is offset by the rapid developmen(t of tolerance to respiratory depression, but, nevertheless, the patient must be watched very carefully during this phase of therapy. Its use for obstetrical analgesia may result in severe fetal respiratory depression.
Morphine cannot be administered to all patients with equal safety. In addition to those patients already mentioned, we have the marked sensitivity of infants and the increased reactivity of the aged. Furthermore, it must be used with caution in patients with liver disease and with hypothyroidism. Nausea and vomiting are very frequent. The occurrence of intense pruritus and urticaria may be very disturbing.
Pupillary constrictions may interfere with the proper management of neurological patients and with the valuable pupillary signs which are followed during general anesthesia.
Depression of the cough reflex may be of value for the treatment of this distressing symptom, but in postoperative patients it interferes with adequate drainage of the respiratory tract and may contribute to the development of postoperative pneumonitis and atelectasis. Because of this action, its use is restricted in patients with chronic lung disease, since it may result in extension of the pathological process.
It is generally accepted that the production of sleep is not a necessary component of analgesia. Yet Patients with chronic pain demand a drug which will not only be effective but will also continue to give the same analgesic effect with the same dose when administered repeatedly. It is well known that this is impossible with morphine. Usually after 2. or 3 weeks of continuous therapy, it will be necessary to increase the dose to achieve the same analgesic action. A point is eventually reached where further tolerance to analgesia no longer occurs and the patient will continue to have relief of pain with a constant but increased dose. Unfortunately, when this stage is reached the patient has cumulated many effects which upon withdrawal of the drug are manifested as addiction symptoms or abstinence phenomena. Although there may be considerable controversy about what is actually meant by addiction, it is difficult to ignore the fact that practically every patient receiving morphine or its derivatives at closely repeated intervals for long periods of time will manifest, upon cessation of the drug, some withdrawal symptoms. These patients may not be aware of their dependence and do not manifest the personality changes which are commonly associated with the accepted conception of an addict. Nevertheless, they have developed a physical dependence to the drug which definitely handicaps their future treatment. This review of morphine in terms of meeting our criteria for a good analgesic is indicative of only one thing. Although morphine meets our first requirement for a potent, efficacious analgesic, it possesses many adverse pharmacological actions that seriously outweigh its therapeutic advantages. We must conclude from the evidence available that morphine and its potent derivatives are not entirely safe drugs. Ever since Serturner in 1803 discovered and isolated morphine from opium the medical profession has accepted its virtues without too much concern over its potentialities to do harm. The pharmacologist and chemist, however, have recognized these disadvantages of morphine. This is well reflected in the hundreds of morphine derivatives that have been synthesized in an effort to alter or remove some detrimental action. Before leaving the subbject of morphine, I would like to raise this question: If we may assume that morphine was not in existence and that it is being introduced today as a new drug with analgesic potentialities, in light of our present knowledge would it be acceptaible to the Food and Drug Administration and released as a safe drug without provisions for adequfate warning as to its dangers?
It is obvious that none of the drugs available today meet all of the requirements demanded for a suitable and effective analgesic agent. Actually, the majority fall far short of our criteria. Thus, there is room for much more work and for the development of drugs which may be of value for clinical analgesia.
In conclusion I wish to stress the importance of the clinical evaluation of analgesic drugs and emphasize the importance of considering the symptom of pain only in relation to the patient as a whole. Unless this is done, we fail in the main objective of these drugs, namely, the temporary symptomatic relief of the condition while the cause is searched for and eradicated.
